Yeast chemical genomics and drug discovery: an update
Authors:
- Robert P. St.ONgeRSRobert P. St.ONge
- Guri GiaeverGGGuri Giaever
- Corey NislowCorey Nislow
- 1 October 2008
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 29 (10) , 499-504
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- The Chemical Genomic Portrait of Yeast: Uncovering a Phenotype for All GenesScience, 2008
- PAP Inhibitor with In Vivo Efficacy Identified by Candida albicans Genetic Profiling of Natural ProductsChemistry & Biology, 2008
- Mechanism-of-Action Determination of GMP Synthase Inhibitors and Target Validation in Candida albicans and Aspergillus fumigatusChemistry & Biology, 2007
- Pharma faces major challenges after a year of failures and heated battlesNature Reviews Drug Discovery, 2007
- Exploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in YeastCell, 2006
- Genome-Wide Requirements for Resistance to Functionally Distinct DNA-Damaging AgentsPLOS Genetics, 2005
- Failing the Public Health — Rofecoxib, Merck, and the FDANew England Journal of Medicine, 2004
- A chemical genomics approach to understanding drug actionTrends in Pharmacological Sciences, 2003
- Functional profiling of the Saccharomyces cerevisiae genomeNature, 2002
- Genomic profiling of drug sensitivities via induced haploinsufficiencyNature Genetics, 1999